NCT05360914

Brief Summary

Many elderly patients with uncomplicated treatment courses are admitted unnecessarily, which is a burden for the patient and society. Studies show that Hospital at Home (HaH) treatment is an alternative to hospitalization. The patient's risk of delirium, infection and loss of function is reduced when the patient avoids the hospital stay. HaH treatment is expected to be more cost-effective, improve patients' functional abilities and patients' satisfaction. Three municipalities, general practitioners, pre-hospital service and an emergency department (ED) in Central Denmark Region have organized the first HaH treatment model across disciplines and sectors. Specialists in the ED and the municipal acute teams provide HaH treatment for elderly acute ill patients. However, the model has not yet been evaluated. The aim of this study is to optimize the HaH treatment model for elderly acute ill patients. The objective is to increase patient satisfaction and optimize the use of resources in healthcare by avoiding unnecessary hospitalizations that impair and prolong treatment. This study is an open label randomized controlled trial (RCT) with a 1:2 allocation ratio of acute hospital admission versus HaH. During a pilot period, we tested and adapted the patient pathway of HaH to the practical reality, before we start the randomization for the RCT study. We will investigate the clinical effects and health economic consequences of HaH treatment compared with standard hospital treatment.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
849

participants targeted

Target at P75+ for not_applicable

Timeline
15mo left

Started Jun 2022

Longer than P75 for not_applicable

Geographic Reach
1 country

3 active sites

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress76%
Jun 2022Aug 2027

First Submitted

Initial submission to the registry

April 21, 2022

Completed
13 days until next milestone

First Posted

Study publicly available on registry

May 4, 2022

Completed
28 days until next milestone

Study Start

First participant enrolled

June 1, 2022

Completed
5.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 1, 2027

Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

5.2 years

First QC Date

April 21, 2022

Last Update Submit

August 6, 2024

Conditions

Outcome Measures

Primary Outcomes (2)

  • Rate of 30-days re-admission

    Rate of 30-days re-admission after discharge

    30 days period after discharge

  • Health Related Quality of Life

    Estimating quality of life by using EuroQoL-5 Dimensions. We will use EuroQoL-5 Dimensions to measure Health Related Quality of Life. The five dimensions include mobility, self-care, usual activity, pain/discomfort and anexiety/depression.This tool will provide us with health states (11111 being the best health state and 55555 the worse health state). We will use the Danish weight to give weights to different health states obtained from EuroQoL-5 Dimensions.

    From inclusion to 3 months follow-up

Secondary Outcomes (3)

  • Functional mobility test

    From inclusion to 3 months follow-up

  • Mortality rate

    From inclusion to 3 months follow-up

  • Number of contacts to primary and secondary health care system

    From inclusion to 3 months follow-up

Study Arms (2)

Hospital at Home (HaH) treatment

EXPERIMENTAL

The patients in this arm will receive the intervention.

Other: Hospital at Home (HaH) treatment

Standard hospital admission

ACTIVE COMPARATOR

The patients in this arm are the control group and will receive the standard hospital treatment.

Other: Standard hospital admission

Interventions

The intervention is a new pathway of providing acut treatment for elderly acute ill patients in their own home. If the patient is randomized to the intervention group, the municipalities acute teams start the treatment. The acute team can take venous blood tests, ECG and bladder scan at home. The acute team handles the treatment at home and follows the patient closely. During the treatment course, the acute team and the ED specialist discuss the treatment process either over the phone or virtually on an iPad, where the patient is also involved. If the specialist would like to see the patient for assessment or send the patient for an X-ray, the specialist informs the acute team that the patient must go to a short check-up in the ED. Here, the specialist examines the patient himself and assesses whether the patient can continue to be treated at home, or whether the patient must be admitted to the hospital due to deterioration of the condition.

Hospital at Home (HaH) treatment

The active comparator is the standard hospital admission for elderly acute ill patients.

Standard hospital admission

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)

You may qualify if:

  • The patient should be aged 65 and over
  • Diagnosed with a stable acute medical conditions e.g. cystitis, erysipelas, pneumonia
  • The patient should be living in their own home or a nursing home before entering the study
  • The patient should be residing in one of the three municipalities (Viborg, Skive and Silkeborg)
  • The patient must have been seen by the GP or the pre-hospital service in the case of disease in question
  • The patient should speak and understand Danish.
  • The patient should give informed consent to participate in the study.

You may not qualify if:

  • The patient is unable to give written consent
  • The capacity of the municipal acut team care was fully utilised.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (3)

Silkeborg municipality

Silkeborg, 8600, Denmark

RECRUITING

Skive municipality

Skive, Denmark

RECRUITING

Viborg municipality

Viborg, Denmark

RECRUITING

Related Publications (10)

  • Creditor MC. Hazards of hospitalization of the elderly. Ann Intern Med. 1993 Feb 1;118(3):219-23. doi: 10.7326/0003-4819-118-3-199302010-00011.

    PMID: 8417639BACKGROUND
  • Leff B, Burton L, Mader SL, Naughton B, Burl J, Greenough WB 3rd, Guido S, Steinwachs D. Comparison of functional outcomes associated with hospital at home care and traditional acute hospital care. J Am Geriatr Soc. 2009 Feb;57(2):273-8. doi: 10.1111/j.1532-5415.2008.02103.x. Epub 2008 Dec 11.

    PMID: 19170781BACKGROUND
  • Isaia G, Astengo MA, Tibaldi V, Zanocchi M, Bardelli B, Obialero R, Tizzani A, Bo M, Moiraghi C, Molaschi M, Ricauda NA. Delirium in elderly home-treated patients: a prospective study with 6-month follow-up. Age (Dordr). 2009 Jun;31(2):109-17. doi: 10.1007/s11357-009-9086-3. Epub 2009 Jan 30.

    PMID: 19507055BACKGROUND
  • Wilson A, Wynn A, Parker H. Patient and carer satisfaction with 'hospital at home': quantitative and qualitative results from a randomised controlled trial. Br J Gen Pract. 2002 Jan;52(474):9-13.

    PMID: 11791829BACKGROUND
  • Aimonino Ricauda N, Tibaldi V, Leff B, Scarafiotti C, Marinello R, Zanocchi M, Molaschi M. Substitutive "hospital at home" versus inpatient care for elderly patients with exacerbations of chronic obstructive pulmonary disease: a prospective randomized, controlled trial. J Am Geriatr Soc. 2008 Mar;56(3):493-500. doi: 10.1111/j.1532-5415.2007.01562.x. Epub 2008 Jan 4.

    PMID: 18179503BACKGROUND
  • Shepperd S, Iliffe S. Hospital at home versus in-patient hospital care. Cochrane Database Syst Rev. 2005 Jul 20;(3):CD000356. doi: 10.1002/14651858.CD000356.pub2.

    PMID: 16034853BACKGROUND
  • Chan AW, Tetzlaff JM, Altman DG, Laupacis A, Gotzsche PC, Krleza-Jeric K, Hrobjartsson A, Mann H, Dickersin K, Berlin JA, Dore CJ, Parulekar WR, Summerskill WS, Groves T, Schulz KF, Sox HC, Rockhold FW, Rennie D, Moher D. SPIRIT 2013 statement: defining standard protocol items for clinical trials. Ann Intern Med. 2013 Feb 5;158(3):200-7. doi: 10.7326/0003-4819-158-3-201302050-00583.

    PMID: 23295957BACKGROUND
  • Levine DM, Ouchi K, Blanchfield B, Saenz A, Burke K, Paz M, Diamond K, Pu CT, Schnipper JL. Hospital-Level Care at Home for Acutely Ill Adults: A Randomized Controlled Trial. Ann Intern Med. 2020 Jan 21;172(2):77-85. doi: 10.7326/M19-0600. Epub 2019 Dec 17.

    PMID: 31842232BACKGROUND
  • Shepperd S, Doll H, Angus RM, Clarke MJ, Iliffe S, Kalra L, Ricauda NA, Wilson AD. Admission avoidance hospital at home. Cochrane Database Syst Rev. 2008 Oct 8;(4):CD007491. doi: 10.1002/14651858.CD007491.

    PMID: 18843751BACKGROUND
  • Thomsen AML, Tayyari N, Duvald I, Kirkegaard H, Obel B, Nielsen CP. Hospital at home for elderly acute patients: a study protocol for a randomised controlled trial. BMJ Open. 2024 May 2;14(5):e083372. doi: 10.1136/bmjopen-2023-083372.

Related Links

MeSH Terms

Conditions

CystitisErysipelasPneumonia

Interventions

Therapeutics

Condition Hierarchy (Ancestors)

Urinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesStreptococcal InfectionsGram-Positive Bacterial InfectionsBacterial InfectionsBacterial Infections and MycosesInfectionsSkin Diseases, BacterialSkin Diseases, InfectiousSkin DiseasesSkin and Connective Tissue DiseasesRespiratory Tract InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Camilla Palmhøj Nielsen, Ph.D

    Defactum, Central Denmark Region

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Camilla Palmhøj Nielsen, Ph.D

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Research director

Study Record Dates

First Submitted

April 21, 2022

First Posted

May 4, 2022

Study Start

June 1, 2022

Primary Completion (Estimated)

August 1, 2027

Study Completion (Estimated)

August 1, 2027

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will not share

Locations